Literature DB >> 19108660

Neuroanatomic comparison of bipolar adolescents with and without cannabis use disorders.

Kelly Jarvis1, Melissa P DelBello, Neil Mills, Igor Elman, Stephen M Strakowski, Caleb M Adler.   

Abstract

OBJECTIVE: Co-occurrence of substance use and bipolar disorders is both common and associated with poor treatment response and greater functional impairment than either disorder alone. The neurophysiological correlates of this co-morbidity however, remain unclear. In this pilot study, we compared brain morphometry between bipolar adolescents with co-occurring cannabis use disorders (CUD) and bipolar adolescents without any substance use disorder.
METHODS: Whole-brain structural magnetic resonance imaging (MRI) scans were obtained from 14 bipolar adolescents. Seven study participants were diagnosed with CUD before and/or shortly after their MR scan was obtained, and 7 subjects were free of any substance use disorder at the time of their MR scan as well as during longitudinal follow up. Morphologic differences were calculated using voxel-based morphometry implemented using statistical parametric mapping software (SPM2).
RESULTS: Bipolar adolescents with co-occurring CUD demonstrated decreased gray matter volume (GMV) in the left fusiform gyrus and increased GMV in the right caudate and precentral gyrus, as well as increased gray matter density in the right middle occipital and fusiform gyri and cerebellar vermis.
CONCLUSIONS: Bipolar adolescents with CUD demonstrate evidence of greater structural abnormalities than adolescents with bipolar disorder alone in frontal and temporal cortical regions, as well as in subcortical areas linked with emotion and motivational regulation. Although the limited prescan exposure to marijuana in these adolescents tentatively suggests that these findings may reflect underlying differences, the direct effect of cannabis exposure may also be involved.

Entities:  

Mesh:

Year:  2008        PMID: 19108660      PMCID: PMC2692725          DOI: 10.1089/cap.2008.033

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  51 in total

1.  Differences between smokers and nonsmokers in regional gray matter volumes and densities.

Authors:  Arthur L Brody; Mark A Mandelkern; Murray E Jarvik; Grace S Lee; Erlyn C Smith; Joe C Huang; Robert G Bota; George Bartzokis; Edythe D London
Journal:  Biol Psychiatry       Date:  2004-01-01       Impact factor: 13.382

2.  Impact of cannabis use on brain function in adolescents.

Authors:  Leslie K Jacobsen; W Einar Mencl; Michael Westerveld; Kenneth R Pugh
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

3.  Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study.

Authors:  Hilary P Blumberg; John H Krystal; Ravi Bansal; Andrés Martin; James Dziura; Kathleen Durkin; Laura Martin; Elizabeth Gerard; Dennis S Charney; Bradley S Peterson
Journal:  Biol Psychiatry       Date:  2006-01-18       Impact factor: 13.382

4.  Gray matter-changes and correlates of disease severity in schizophrenia: a statistical parametric mapping study.

Authors:  M Wilke; C Kaufmann; A Grabner; B Pütz; T C Wetter; D P Auer
Journal:  Neuroimage       Date:  2001-05       Impact factor: 6.556

Review 5.  Neuroimaging in bipolar disorder.

Authors:  S M Strakowski; M P DelBello; C Adler; D M Cecil; K W Sax
Journal:  Bipolar Disord       Date:  2000-09       Impact factor: 6.744

Review 6.  Frontotemporal neural systems in bipolar disorder.

Authors:  Hilary P Blumberg; Dennis S Charney; John H Krystal
Journal:  Semin Clin Neuropsychiatry       Date:  2002-10

Review 7.  Cocaine addiction as a neurological disorder: implications for treatment.

Authors:  M D Majewska
Journal:  NIDA Res Monogr       Date:  1996

Review 8.  Addiction.

Authors:  A R Lingford-Hughes; S J C Davies; S McIver; T M Williams; M R C Daglish; D J Nutt
Journal:  Br Med Bull       Date:  2003       Impact factor: 4.291

9.  A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices.

Authors:  Hilary P Blumberg; Hoi-Chung Leung; Pawel Skudlarski; Cheryl M Lacadie; Carolyn A Fredericks; Brent C Harris; Dennis S Charney; John C Gore; John H Krystal; Bradley S Peterson
Journal:  Arch Gen Psychiatry       Date:  2003-06

10.  The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

Authors:  M B Keller; P W Lavori; B Friedman; E Nielsen; J Endicott; P McDonald-Scott; N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1987-06
View more
  18 in total

1.  Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.

Authors:  Abir T El-Alfy; Kelly Ivey; Keisha Robinson; Safwat Ahmed; Mohamed Radwan; Desmond Slade; Ikhlas Khan; Mahmoud ElSohly; Samir Ross
Journal:  Pharmacol Biochem Behav       Date:  2010-03-21       Impact factor: 3.533

2.  Increased marijuana use and gender predict poorer cognitive functioning in adolescents and emerging adults.

Authors:  Krista M Lisdahl; Jenessa S Price
Journal:  J Int Neuropsychol Soc       Date:  2012-05-22       Impact factor: 2.892

Review 3.  The underlying neurobiology of key functional domains in young people with mood and anxiety disorders: a systematic review.

Authors:  Frank Iorfino; Ian B Hickie; Rico S C Lee; Jim Lagopoulos; Daniel F Hermens
Journal:  BMC Psychiatry       Date:  2016-05-23       Impact factor: 3.630

4.  Brain circuitry associated with the development of substance use in bipolar disorder and preliminary evidence for sexual dimorphism in adolescents.

Authors:  Elizabeth T C Lippard; Carolyn M Mazure; Jennifer A Y Johnston; Linda Spencer; Judah Weathers; Brian Pittman; Fei Wang; Hilary P Blumberg
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

5.  Anterior cingulate volume reductions in abstinent adolescent and young adult cannabis users: Association with affective processing deficits.

Authors:  Kristin E Maple; Alicia M Thomas; Megan M Kangiser; Krista M Lisdahl
Journal:  Psychiatry Res Neuroimaging       Date:  2019-04-30       Impact factor: 2.376

6.  The impact of ADHD persistence, recent cannabis use, and age of regular cannabis use onset on subcortical volume and cortical thickness in young adults.

Authors:  Krista M Lisdahl; Leanne Tamm; Jeffery N Epstein; Terry Jernigan; Brooke S G Molina; Stephen P Hinshaw; James M Swanson; Erik Newman; Clare Kelly; James M Bjork
Journal:  Drug Alcohol Depend       Date:  2016-02-06       Impact factor: 4.492

7.  Predictors of first-onset substance use disorders during the prospective course of bipolar spectrum disorders in adolescents.

Authors:  Benjamin I Goldstein; Michael Strober; David Axelson; Tina R Goldstein; Mary Kay Gill; Heather Hower; Daniel Dickstein; Jeffrey Hunt; Shirley Yen; Eunice Kim; Wonho Ha; Fangzi Liao; Jieyu Fan; Satish Iyengar; Neal D Ryan; Martin B Keller; Boris Birmaher
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-07-31       Impact factor: 8.829

8.  Cortico-cerebellar abnormalities in adolescents with heavy marijuana use.

Authors:  Melissa P Lopez-Larson; Jadwiga Rogowska; Piotr Bogorodzki; Charles Elliott Bueler; Erin C McGlade; Deborah A Yurgelun-Todd
Journal:  Psychiatry Res       Date:  2012-07-24       Impact factor: 3.222

Review 9.  Brain changes in early-onset bipolar and unipolar depressive disorders: a systematic review in children and adolescents.

Authors:  Gianluca Serafini; Maurizio Pompili; Stefan Borgwardt; Josselin Houenou; Pierre Alexis Geoffroy; Renaud Jardri; Paolo Girardi; Mario Amore
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-09-12       Impact factor: 4.785

10.  N-acetyl aspartate levels in adolescents with bipolar and/or cannabis use disorders.

Authors:  Samantha M Bitter; Wade A Weber; Wen-Jang Chu; Caleb M Adler; James C Eliassen; Stephen M Strakowski; Melissa P DelBello
Journal:  J Dual Diagn       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.